2021-2022 EEH Enduring Program: Updates on COVID-19 Vaccines and Allergic Reactions, Contraindications & Precautions for Covid-19 Vaccines

Course Instructions

Registration is not required for this online event, however, due to requirements of our CME accreditation, credits are not applied until the Post-Test and evaluation/follow-up survey are completed.

Release date:  February 1, 2021                        Expiration date:  February 1, 2022

Completion Requirements:  To gain credit for this online activity, participants must view the video, read the corresponding articles, complete the post-test with a 100% pass rate, and complete the evaluation and follow-up survey. Participants will have one attempt to complete the post-test.

Technology Requirements:  Participants will need a computer with access to the internet, sound, and a mechanism to view the video recording to complete this course.

Estimated Completion Time:  1.5 hours.

Wednesday, February 3, 2021, 8:00 AM - Thursday, February 3, 2022, 9:30 AM, Online Enduring

The COVID-19 vaccination completion rates are now in the hundreds of thousands. The CDC has released the latest updates on contraindications, allergic reactions, and precautions for Covid-19 vaccines. While previously the agency released guidelines for contraindication to vaccination, it's now broadened to include those with a history of immediate allergic reaction to a previous dose of or any component of mRNA COVID-19 vaccines, including polyethylene glycol. Anyone with a history of immediate allergic reaction of any severity to any component of mRNA COVID-19 vaccines, or to polysorbate should not be vaccinated, according to the CDC in its updated guidelines. This enduring activity from the Centers for Disease Control and Prevention and the Center for Preparedness and Response discusses the recommendations for use of COVID-19 vaccines in certain populations. Providers will learn more about the recent reports on anaphylaxis following vaccination, as well as CDC’s updated clinical considerations around contraindications and precautions to vaccination.

1. 1. Describe the implications for clinicians for patient populations not recommended for vaccination.
2. 2. Discuss concerns related to preparedness and responses to the urgent public health threats of COVID-19.
3. 3. Promote health improvement with other members of interprofessional teams of health care providers through support of wellness and disease prevention in cooperation with patients, communities, and at-risk populations, by managing vaccination of patients safely and appropriately.

AMA PRA Category 1 Credits™ (1.50 hours), Non-Physician Attendance (1.50 hours)


Disclosures:

No one involved in the approval, planning, or presentation of this activity has disclosed any relevant conflict of any interest with any commercial entity.